Advertisement

Topics

InB:Hauser Pharmaceuticals Services Inc Company Profile

12:44 EST 17th December 2018 | BioPortfolio

InB:Hauser is a world leader in the extraction, isolation, purification and synthetic modification of natural products from plant, marine and microbial sources. InB:Hauser provides research, process development, analytical services, manufacturing, compliance services and consulting to produce compounds from natural raw materials for the pharmaceutical, dietary supplement and fine chemical industries

Location

6880 North Broadway, Suite H
Denver
Colorado
80221
United States of America

Contact

Phone: (720) 406-4700
Fax: (303) 412-8644
Email: problem.solving@hausercro.com


News Articles [434 Associated News Articles listed on BioPortfolio]

Natalie Hauser is recognized by Continental Who's Who

WESTFIELD, Ind., Sept. 17, 2018 /PRNewswire/ -- Natalie Hauser, CPNP is recognized by Continental Who's Who as a Pinnacle Professional Member in the field of Read more...

Saudi calibration centre creates opportunity for Endress+Hauser

Endress+Hauser has opened a calibration and training centre in Saudi Arabia’s industrial heartland of Jubail, at a cost of some €3million.

M&As this week: Telix Pharmaceuticals, PCI Pharma, DZS Clinical Services

Telix Pharmaceuticals Limited has acquired Atlab Pharma SAS for $10m. Based in Australia, Telix is a clinical-stage biotechnology company engaged...Read More... The post M&As this week: Telix Pha...

2CELLOS Announce New Album Let There Be Cello Availalble October 19 -- Preorder Now

NEW YORK, Aug. 17, 2018 /PRNewswire/ -- The Croatian duo of Luka Sulic and Stjepan Hauser, better known as 2CELLOS, return this Fall with an Read more...

Sigma Pharmaceuticals Limited Strategy, SWOT and Corporate Finance Report [Report Updated: 28072018] Prices from USD $175

Sigma Pharmaceuticals Limited Strategy, SWOT and Corporate Finance ReportSummarySigma Pharmaceuticals Limited Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data a...

Global Total Organic Carbon Analyzer Market Status and Outlook 20182025 [Report Updated: 15082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Catalent Signs Agreement to Acquire Juniper Pharmaceuticals

Catalent (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, announced that it has agreed to acquire...

U.S. Centers for Medicare and Medicaid Services (CMS) Grants New Technology Add-On Payment for Portola Pharmaceuticals’ Andexxa

SOUTH SAN FRANCISCO, Calif. , Aug. 03, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has gra...

PubMed Articles [958 Associated PubMed Articles listed on BioPortfolio]

The Interest of Women with Mayer-Rokitansky-Küster-Hauser Syndrome and Laparoscopic Vecchietti Neovagina in Uterus Transplantation.

The goal of this study was to assess a group of Mayer-Rokitansky-Küster-Hauser syndrome (MRKH) women with surgically created neovaginas in the interest of uterus transplantation (UTx) and to recruit ...

Combined laparoscopic and vaginal cervicovaginal reconstruction using acellular porcine small intestinal submucosa (SIS) graft in a patient with Mayer-Rokitansky-Küster-Hauser syndrome (U5aC4V4).

To introduce a creation that combines laparoscopic and Wharton-Sheares-George cervicovaginal reconstruction using SIS graft in a patient with Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome who had a ...

Spectrum of Type I and Type II syndromes and associated malformations in Chinese patients with Mayer-Rokitansky-Küster-Hauser syndrome: A retrospective analysis of 274 cases.

To analyze the spectrum of Type I and Type II malformations in Chinese patients with Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome.

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Ultrasound-guided follicle aspiration at time of laparotomy in a patient with Mayer-Rokitansky-Küster-Hauser syndrome.

To demonstrate a unique case of direct ultrasound-guided follicle aspiration at time of a laparotomy in a patient with Mayer-Rokitansky-Küster-Hauser Syndrome.

Clinical Trials [1373 Associated Clinical Trials listed on BioPortfolio]

Molecular Genetic Study of Mayer-Rokitansky-Kuster-Hauser Syndrome

In order to understand the molecular mechanisms leading to Mayer-Rokitansky-Kuster-Hauser syndrome (MRKH), the research team has to identify molecular bases of this anomaly. Toward this g...

Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)

In France, one in 4500 women is affected by the MayerRokitantskyKüsterHauser (MRKH) syndrome which is characterized by the absence of uterus at birth. Currently, the only solutions for th...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Companies [1959 Associated Companies listed on BioPortfolio]

InB:Hauser Pharmaceuticals Services Inc

InB:Hauser is a world leader in the extraction, isolation, purification and synthetic modification of natural products from plant, marine and microbial sources. InB:Hauser provides research, process d...

HAUSER GmbH

HAUSER's purpose is not just to sell refrigerated cabinets, but the core of HAUSER's philosophy is the use of Project Management to create an integrated system combining expert refrigeration engineeri...

HAUSER LABORATORIES

Hauser Laboratories is a research and development testing laboratory that provides research, development, testing, and expert witness services to the following industries: pharmaceutical, natural prod...

Zeta Pharmaceuticals Inc.

For those of you who know us as Zetapharm, the name of our company has been changed to Zeta Pharmaceuticals Inc. This reflects our acquiring the assets of Zetapharm from Hauser Inc. in late March 200...

Endress+Hauser Metso AG

Nil

More Information about "InB:Hauser Pharmaceuticals Services Inc" on BioPortfolio

We have published hundreds of InB:Hauser Pharmaceuticals Services Inc news stories on BioPortfolio along with dozens of InB:Hauser Pharmaceuticals Services Inc Clinical Trials and PubMed Articles about InB:Hauser Pharmaceuticals Services Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InB:Hauser Pharmaceuticals Services Inc Companies in our database. You can also find out about relevant InB:Hauser Pharmaceuticals Services Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record